J Chem Technol Biotechnol 91(8):23492359
References Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, Koszegi Z, Bacon A, Jones BJ, Lucey MA, Sasaki S, Brierley DI, Hastoy B, Tomas A, DAgostino G, Reimann F, Lynn FC, Reissaus CA, Linnemann AK, DEste E, Calebiro D, Trapp S, Johnsson K, Podewin T, Broichhagen J, Hodson DJ
Focus on Bioavailability & Delivery Systems : Liposomal and transdermal delivery methods are being adopted to enhance ingredient stability and skin penetration
IGF-1 LR3 has been extensively used in muscle satellite cell research, bone biology, neuroprotection models, and metabolic signaling studies as a surrogate for sustained IGF-1 receptor activation
78 These findings have been replicated across multiple studies in animals and humans, with GLP-1R agonism consistently reducing intestinal TRLapoB 48 production and postprandial triglyceride excursions largely independent of weight loss